Cheryl Guttman Krader
OCTA brings understanding to managing diabetic eye disease
Optical coherence tomography angiography (OCTA) is a promising new approach for visualizing retinal vascular pathology in eyes with diabetic eye disease that can be expected to have even greater utility in the future pending further enhancements.
Laser retains limited role for management of RVO-related ME
In the current era where pharmacologic therapy is the preferred treatment for macular edema secondary to retinal vein occlusion (RVO), there is still a role for laser, according to Francesco Bandello, MD.
Anti-angiogenic agent, platform planned for human trial
Findings from preclinical studies show that a novel intravitreal depot of an anti-angiogenic drug releases the medication over a period of at least 6 months, is well-tolerated, and prevents VEGF-induced retinal vascular leakage.
Retinectomy-under-air solution for retina reattachment
Retinectomy-under-air solution for retina reattachment
In complicated retinal detachment cases where the retina fails to reattach after completing the usual steps, retinectomy is a better technique than relaxing retinotomy–and the retinectomy is best done incrementally under air, said Steve Charles, MD.
New therapies for uveal melanoma target radiation toxicity, metastatic risk
Ongoing research for the treatment of uveal melanoma is providing hope that the future may bring new approaches for improving the safety of local therapy–along with modalities that will increase survival by reducing metastatic risk.
Topical cetirizine latest therapy to treat allergic conjunctivitis
Oral cetirizine is one of the most used oral medications for treatment of allergic rhinitis. In May 2017, the FDA approved the first ophthalmic formulation of the second-generation histamine-1 (H1) receptor antagonist for use in treating ocular itching associated with allergic conjunctivitis.
SMILE procedure brings potential advantages to hyperopic correction
Hyperopic SMILE is being investigated in a prospective study. Early outcomes show good efficacy, safety, and predictability along with some interesting differences compared with hyperopic LASIK.
Vector planning delivers superior outcomes for myopic astigmatism
Excimer laser treatments using vector planning resulted in less corneal astigmatism, less refractive cylinder, and better unaided visual acuity postoperatively than treatments using manifest refractive treatment parameters alone, according to Noel Alpins, MD.
Tool provides standard for assessing LASIK patient-reported outcomes
A new questionnaire can help assess candidates’ symptoms before LASIK surgery, monitor them for visual symptoms as well as satisfaction after LASIK surgery, and measure the impact any post-LASIK symptoms have on a patient’s ability to function.
QoL better with bladder Ca immunotherapy vs. chemo
Patients treated with pembrolizumab (Keytruda) as second-line therapy for advanced urothelial carcinoma following platinum-based chemotherapy maintain better health-related quality of life than their counterparts receiving chemotherapy, according to results from the phase III KEYNOTE-045 trial presented at the American Society of Clinical Oncology annual meeting in Chicago.

Poll

View Results